Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medclair ABNGM:MCLR -1.35%68 10-Year Share Buyback Ratio is -41.50 as of Jun. 2026. GuruFocus rates NGM:MCLR with a GF Score™ of 68/100 and a GF Value™ of kr2.22 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 451 Medical Devices & Instruments companies, Medclair AB ranks worse than 94.68% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Medclair AB's current 10-Year Share Buyback Ratio was -41.50%.
NGM:MCLR's 10-Year Share Buyback Ratio is ranked worse than 94.68% of 451
companies
in the Medical Devices & Instruments industry
Industry Median: -3.3
vs NGM:MCLR: -41.50
Medclair AB (NGM:MCLR) 10-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Medclair AB 10-Year Share Buyback Ratio Related Terms
NGM:MCLR vs ABT, SYK, MDT: 10-Year Share Buyback Ratio Comparison
For the Medical Devices subindustry, Medclair AB's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medclair AB 10-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's 10-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Medclair AB's 10-Year Share Buyback Ratio falls into.
Medclair AB 10-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 10-Year Share Buyback Ratio of -41.50 mean?
Medclair AB (NGM:MCLR) has a 10-Year Share Buyback Ratio of -41.50 as of Jun. 2026. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Medclair AB and its competitors. According to the industry distribution chart, Medclair AB ranks #427 out of 451 companies in the Medical Devices & Instruments industry, placing it in the top 94.7%.
Is Medclair AB's 10-Year Share Buyback Ratio too high?
Medclair AB's current 10-Year Share Buyback Ratio is -41.50. Based on the distribution chart, Medclair AB ranks #427 out of 451 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medclair AB has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medclair AB's 10-Year Share Buyback Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medclair AB ranks #427 out of 451 companies for 10-Year Share Buyback Ratio. This places Medclair AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 10-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 10-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Share Buyback Ratio mean?
A high 10-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Medclair AB and its competitors. Medclair AB's current 10-Year Share Buyback Ratio is -41.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medclair AB stock overvalued right now?
Based on GuruFocus' analysis, Medclair AB (NGM:MCLR) is currently considered Significantly Overvalued. The stock's GF Value™ is kr2.22, compared to a current price of kr2.92 — trading 31.5% above its estimated fair value. The current 10-Year Share Buyback Ratio is -41.50. Medclair AB's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Share Buyback Ratio calculated?
10-Year Share Buyback Ratio is calculated from a company's financial statements. For Medclair AB (NGM:MCLR), the current 10-Year Share Buyback Ratio is -41.50 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medclair AB (NGM:MCLR) Overvalued in 2026?
Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued.
The current stock price of kr2.92 is trading 31.5% above its estimated GF Value™ of kr2.22.
GuruFocus considers Medclair AB to be Significantly Overvalued.
Key valuation signals for NGM:MCLR:
10-Year Share Buyback Ratio: -41.50
GF Value™: kr2.22 vs. price of kr2.92 (31.5% above fair value)
No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
68GF Score
Get the complete analysis for NGM:MCLR
10-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:MCLR has been successfully added to your 
